title: [ALK-positive large B-cell lymphoma: report of a case].
authors.forename: Hong
authors.initials: H
authors.lastname: Yu
authors.forename: Jun-xing
authors.initials: JX
authors.lastname: Huang
authors.forename: Chao-fu
authors.initials: CF
authors.lastname: Wang
authors.forename: Da-ren
authors.initials: DR
authors.lastname: Shi
mesh_terms: D000328:Adult; D000077548:Anaplastic Lymphoma Kinase; D000911:Antibodies, Monoclonal / Q000378:metabolism; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D017493:Leukocyte Common Antigens / Q000378:metabolism; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D008297:Male; D018396:Mucin-1 / Q000378:metabolism; D011241:Prednisone / Q000627:therapeutic use; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D018396:Mucin-1; C100347:VS38 monoclonal antibody; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D020794:Receptor Protein-Tyrosine Kinases; D017493:Leukocyte Common Antigens; D011241:Prednisone